Crispr Therapeutics Ag (CRSP)

09:43 AM

Genome Editing Market Is Going to Boom |• CRISPR Therapeutics • Editas Medicine - openpr.com

09:43 AM

Apr 05, 2026

CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 05, 2026

Apr 05, 2026

CRISPR Therapeutics AG (CRSP) stock price, news, quote and history - Yahoo Finance UK

Apr 05, 2026

Apr 05, 2026

CRISPR Therapeutics AG (CRSP) latest stock news and headlines - Yahoo Finance Australia

Apr 05, 2026

Apr 04, 2026

Assessing CRISPR Therapeutics (CRSP) Valuation As Casgevy Revenue And Cash Position Support Its Growth Transition - Sahm

Apr 04, 2026

Apr 04, 2026

LTS:0VRQ PB Ratio: 2.47 — 22% Below Median - GuruFocus

Apr 04, 2026

Apr 03, 2026

CRISPR Therapeutics Hits Day Low of $50.66 Amid Price Pressure - Markets Mojo

Apr 03, 2026

Apr 03, 2026

Did CRISPR’s Cash Raise, Casgevy Launch and Insider Buying Just Shift CRISPR Therapeutics' (CRSP) Investment Narrative? - Sahm

Apr 03, 2026

Apr 03, 2026

symbol__ Stock Quote Price and Forecast - CNN

Apr 03, 2026

Apr 02, 2026

CRISPR Therapeutics AG (CRSP) rises higher than market: Key facts - MSN

Apr 02, 2026

Apr 02, 2026

CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts - Yahoo Finance

Apr 02, 2026

Apr 02, 2026

CRISPR Therapeutics (NASDAQ: CRSP) asks shareholders to approve pay, capital and equity plan - stocktitan.net

Apr 02, 2026

Apr 02, 2026

CRISPR Therapeutics AG (0VRQ.L) stock price, news, quote and history - Yahoo Finance UK

Apr 02, 2026

Apr 02, 2026

CRISPR Therapeutics AG (CRSP) exceeds market returns: Some facts to consider - MSN

Apr 02, 2026

Apr 01, 2026

CRISPR Therapeutics AG (CRSP) Outperforms the Market: Key Points to Note - Bitget

Apr 01, 2026

Apr 01, 2026

CRISPR Therapeutics AG (CRSP) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance

Apr 01, 2026

Apr 01, 2026

Earnings Beat: Is CRISPR Therapeutics AG backed by strong institutional buying2026 Institutional Moves & Low Risk Entry Point Tips - baoquankhu1.vn

Apr 01, 2026

Apr 01, 2026

A Turning Point For Crispr Therapeutics As Commercial Growth Accelerates (NASDAQ:CRSP) - Seeking Alpha

Apr 01, 2026

Apr 01, 2026

Bond Watch: Is CRISPR Therapeutics AG backed by strong institutional buying2026 Chart Watch & Weekly High Return Stock Opportunities - baoquankhu1.vn

Apr 01, 2026

Mar 31, 2026

Mizuho Securities Reaffirms Their Buy Rating on Crispr Therapeutics AG (CRSP) - The Globe and Mail

Mar 31, 2026

Mar 31, 2026

I Expect Crispr Therapeutics To Break Out As 2026 Revenue Exceeds Expectations (CRSP) - Seeking Alpha

Mar 31, 2026

Mar 31, 2026

CRISPR Therapeutics: The Fundamental Standard-Bearer in a Fractured Genomic Sector - Barchart

Mar 31, 2026

Mar 31, 2026

CRISPR (CRSP) Rated Overweight on Gene Editing Growth - Insider Monkey

Mar 31, 2026

Mar 31, 2026

CRISPR Therapeutics AG Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo

Mar 31, 2026

Mar 30, 2026

CRISPR Therapeutics shares drop after announcing convertible notes sale - MSN

Mar 30, 2026

Mar 29, 2026

Return on equity % of CRISPR Therapeutics AG Shs Thailand Depositary Receipts Repr 1 Sh – SET:CRSP03 - TradingView

Mar 29, 2026

Mar 29, 2026

(CRSP) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Mar 29, 2026

Mar 28, 2026

Is CRISPR Therapeutics (CRSP) Attractive After Recent Share Price Pullback? - Yahoo Finance

Mar 28, 2026

Mar 28, 2026

Why CRISPR Therapeutics AG (CRSP) outpaced the stock market today - MSN

Mar 28, 2026

Mar 27, 2026

Trend Report: What is the long term forecast for CRISPR Therapeutics AG stockTrade Entry Report & Accurate Intraday Trading Signals - baoquankhu1.vn

Mar 27, 2026

Mar 26, 2026

CRISPR Therapeutics stock faces uncertainty ahead of key earnings amid biotech sector volatility - AD HOC NEWS

Mar 26, 2026

Mar 26, 2026

Truist Financial Upgrades CRISPR Therapeutics (NASDAQ:CRSP) to "Strong-Buy" - marketbeat.com

Mar 26, 2026

Mar 25, 2026

CRISPR Therapeutics AG (CRSP) is a trending stock: Facts to know before betting on it - msn.com

Mar 25, 2026

Mar 25, 2026

Why CRISPR Therapeutics AG (CRSP) Performed Better Than the Market Today - Bitget

Mar 25, 2026

Mar 25, 2026

Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today - Yahoo! Finance Canada

Mar 25, 2026

Mar 25, 2026

CRISPR Therapeutics stock dips on $350M convertible debt offering - MSN

Mar 25, 2026

Mar 25, 2026

CRISPR Therapeutics (NASDAQ:CRSP) General Counsel James Kasinger Sells 3,182 Shares - MarketBeat

Mar 25, 2026

Mar 25, 2026

CRISPR Therapeutics (NASDAQ:CRSP) CEO Sells 10,020 Shares - marketbeat.com

Mar 25, 2026